DJIA 15,318.23 138.38 0.91%
NASDAQ 3,482.18 30.05 0.87%
S&P 500 1,651.81 12.77 0.78%
market minute promo

STAAR Surgical Company

NASDAQ: STAA

10.51 1.04 (10.98%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

STAA $10.51 10.98%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.52
Previous Close $9.47
Daily Range $9.42 - $10.81
52-Week Range $4.96 - $10.81
Market Cap $386.2M
P/E Ratio -189.40
Dividend (Yield) $0.00 (0.0%)
Volume 904,735
Average Daily Volume 160,283
Current FY EPS $0.14

Sector

Healthcare

Industry

Healthcare Information Services

STAAR Surgical Company (STAA) Description

The Company develops and manufactures minimally invasive visual implants and other ophthalmic products to improve or correct the vision of patients with cataracts and refractive conditions and distributes them worldwide. Website: http://www.staar.com/

News & Commentary Rss Feed

STAAR Surgical Receives Regulatory Approvals for Visian ICL with CentraFLOW Technology in Korea, Arg

STAAR Surgical Receives Regulatory Approvals for Visian ICL with CentraFLOW Technology in Korea, Argentina

This Metric Suggests You're Right to Own STAAR Surgical.

Don't just ask, "How much inventory?" Ask, "What kind?"

STAAR's CEO Presents at 38th Annual Deutsche Bank 2013 Healthcare Conference (Transcript)

Luxottica Group, S.p.A. (LUX) Ex-Dividend Date Scheduled for May 20, 2013

STAAR Surgical Company's CEO Discusses Q1 2013 Results - Earnings Call Transcript

LCA-Vision: The Case For Calculated Optimism

STAAR Surgical Company CEO Presents at ASCRS Symposium on Cataract and Refractive Surgery (Transcrip

STAAR Surgical Company CEO Presents at ASCRS Symposium on Cataract and Refractive Surgery (Transcript)

Panel Backing For Lens Rewards Bausch & Lomb's Focus On Devices

Morning Market Movers

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

See More STAA News...

STAA's Top Competitors

STAA $10.51 (10.98%)
Current stock: STAA
BAX $70.88 (0.21%)
Current stock: BAX
$0.00 (0.00%)
Current stock:
COV $65.94 (-0.50%)
Current stock: COV